COVID-19 Vaccines & Spondyloarthritis

On Wednesday, December 9th, 2020, the Spondylitis Association of America hosted a dynamic Facebook Live discussion, “COVID-19 Vaccines & Spondyloarthritis.” This information-packed live conversation featured two special guests – Dr. James Rosenbaum, rheumatologist, and Dr. Kevin Winthrop, infectious disease epidemiologist – answering our community’s most pressing questions about the upcoming COVID-19 vaccines and key impacts and considerations for the spondyloarthritis (SpA) community.

You can now watch the recorded video of this live broadcast on SAA’s YouTube channel. Watch the video now to learn what medical experts have to say about crucial questions, including: Will the vaccine be safe for people with SpA? Does the vaccine interact with biologic medications? Will those with SpA be considered high-risk in terms of vaccine roll-out? Watch below to hear the entire discussion!

Dr. James Rosenbaum

Professor of Medicine at the Division of Arthritis & Rheumatic Diseases, as well as Professor of Ophthalmology at OHSU

Dr. Kevin Winthrop

Professor of Infectious Diseases, Public Health, and Ophthalmology at OHSU, and former infectious disease epidemiologist at the U.S. Centers for Disease Control and Prevention (CDC)

Have questions or need additional assistance? Please contact us at Programs@spondylitis.org.

Donations by members of the SAA, including our corporate member Novartis, support our COVID-19 resources.

The Spondylitis Association of America is solely responsible for all of the content hosted on spondylitis.org.